Top compounds associated with response to MTRNR2L4


Feature Type Standardized
Nominal ANOVA
mRNA dacarbazine CTRPv2 pan-cancer AAC -0.065 0.05
mRNA GSK1120212 CTRPv2 pan-cancer AAC -0.1 0.05
mRNA 5-FU CTRPv2 pan-cancer AAC -0.068 0.06
mRNA ciclopirox CTRPv2 pan-cancer AAC -0.065 0.06
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.072 0.06
mRNA BRD-K09344309 CTRPv2 pan-cancer AAC 0.15 0.06
mRNA selumetinib:JQ-1 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.068 0.06
mRNA CBB-1007 CTRPv2 pan-cancer AAC 0.11 0.06
mRNA Methotrexate CTRPv2 pan-cancer AAC -0.073 0.07
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.067 0.07
Download CSV